You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Ravgen, Inc. v. Natera, Inc. (W.D. Tex. 2020)

✉ Email this page to a colleague

« Back to Dashboard

Ravgen, Inc. v. Natera, Inc. (W.D. Tex. 2020)

Docket	⤷ Sign Up	Date Filed	2020-06-01
Court	District Court, W.D. Texas	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Alan D. Albright
Jury Demand	Plaintiff	Referred To
Patents	7,727,720
Link to Docket	External link to docket

Biologic Drugs cited in Ravgen, Inc. v. Natera, Inc.

The biologic drugs covered by the patent cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Ravgen, Inc. v. Natera, Inc. (W.D. Tex. 2020)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2020-06-01	1		United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively…collectively the “Patents-in-Suit”), arising under the Patent Laws of the United States, 35 U.S.C. §§ 271, et…resulted in the issuance of several patents, including the Patents-in-Suit. Case 1:20-cv-00692…United States Patent and Trademark Office on February 19, 2008. The inventor of the patent is Ravinder …Ravinder S. Dhallan, and the patent is assigned to Ravgen. A copy of the ’277 Patent is attached hereto as Exhibit	External link to document
2021-10-01	114	Sealed Motion - Patent Cases only	JUDGMENT REGARDING INVENTORSHIP OF U.S. PATENT NOS. 7,332,277 AND 7,727,720 by Ravgen, Inc. (Attachments: # 1… 1 June 2020 1:20-cv-00692 830 Patent Both District Court, W.D. Texas	External link to document
2021-10-08	122	Notice of Filing - Redacted Public Version	JUDGMENT REGARDING INVENTORSHIP OF U.S. PATENT NOS. 7,332,277 AND 7,727,720 by Ravgen, Inc. by Ravgen, Inc.. … 1 June 2020 1:20-cv-00692 830 Patent Both District Court, W.D. Texas	External link to document
2021-10-15	137	Sealed Document - Patent Cases only	JUDGMENT REGARDING INVENTORSHIP OF U.S. PATENT NOS. 7,332,277 AND 7,727,720 by Ravgen, Inc. by NSTX, Inc., Natera… 1 June 2020 1:20-cv-00692 830 Patent Both District Court, W.D. Texas	External link to document
2021-10-22	156	Sealed Document - Patent Cases only	JUDGMENT REGARDING INVENTORSHIP OF U.S. PATENT NOS. 7,332,277 AND 7,727,720 of 114 Sealed Motion PLAINTIFF RAVGEN…JUDGMENT REGARDING INVENTORSHIP OF U.S. PATENT NOS. 7,332,277 AND 7,727,720 by Ravgen, Inc., 137 Sealed Document… 1 June 2020 1:20-cv-00692 830 Patent Both District Court, W.D. Texas	External link to document
2021-10-28	164	Pretrial Disclosures	7,727,720 (the “’720 Patent”) (collectively the “Asserted Patents”). See Dkt. 1. Dr. Ravinder S. Dhallan…Inventorship of U.S. Patent Nos. 7,332,277 and 7,727,720 (Dkt. 114) Oct. 1, 2021 Plaintiff…alleging patent infringement of Ravgen’s United States Patent Nos. 7,332,277 (the “’277 Patent”) and 7,727,720…invalidate the patents. 2 21. The Asserted Claims of the ’277 and ’720 Patents are not patent ineligible… This is a civil action for patent infringement arising under the patent laws of the United States,	External link to document
2021-11-02	169	Notice of Filing - Redacted Public Version	JUDGMENT REGARDING INVENTORSHIP OF U.S. PATENT NOS. 7,332,277 AND 7,727,720 of 156 Sealed Document, by Ravgen… 1 June 2020 1:20-cv-00692 830 Patent Both District Court, W.D. Texas	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.